News

It would have been interesting to have sat in on the senior management meetings at Merck that thrashed out the Organon ...
Thank you for joining Organon's first quarter earnings call ... Renflexis and Hadlima are mainly supplied from Korea and the EU. For recently acquired Tofidence, that product is manufactured in China, ...
This news release contains certain forward-looking statements relating to BAT8006, BAT8008, BAT8010, BAT1006, BAT1308 or the product pipelines in general of Bio-Thera Solutions. Readers are ...
In another development, Organon has acquired the U.S. rights to TOFIDENCE™, a biosimilar to ACTEMRA®, from Biogen, further expanding its arthritis treatment portfolio. Furthermore, Biogen plans ...
In another development, Organon has acquired the U.S. rights to TOFIDENCE™, a biosimilar to ACTEMRA®, from Biogen, further expanding its arthritis treatment portfolio. Furthermore, Biogen plans to ...
This news release contains certain forward-looking statements relating to BAT8006, BAT8008, BAT8010, BAT1006, BAT1308 or the product pipelines in general of Bio-Thera Solutions. Readers are strongly ...